Chugai Pharmaceutical Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and | Outperform |
16
|
$766.68 | $636.99 | 14.78% | 9 | $690.32B |
| JNJ | Johnson & Johnson | Outperform |
9
|
$148.58 | $174.55 | 14.42% | 3 | $357.58B |
| ABBV | AbbVie | Outperform |
9
|
$162.73 | $178.42 | 13.69% | 11 | $287.36B |
| AZN | AstraZeneca PLC | Outperform |
17
|
£120.50 | £165.99 | 35.23% | 16 | £186.80B |
| ROG | Roche Holding | Hold |
16
|
CHF218.50 | CHF307.83 | 24.71% | 9 | CHF176.21B |
| PFE | Pfizer | Outperform |
2
|
$28.16 | $32.87 | 8.31% | 6 | $159.46B |
| SAN | Sanofi | Outperform |
16
|
91.02€ | 102.80€ | 19.75% | 9 | 113.65€B |
| REGN | Regeneron Pharmaceuticals | Outperform |
2
|
$958.64 | $961.26 | 9.53% | 8 | $105.63B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$43.90 | $58.15 | 23.01% | 10 | $88.99B |
| GSK | GSK | Outperform |
12
|
£17.34 | £17.30 | 12.46% | 12 | £70.69B |